跳至主要内容
临床试验/NCT02112825
NCT02112825已完成不适用

Exercise as an Adjunct Therapy to Reduce Blood Pressure in Chronic Kidney Disease

University of Minnesota1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2013年7月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
40
试验地点
1
主要终点
blood pressure

研究概览

简要总结

The general objective of the study is to investigate the effect of regular aerobic exercise on resting and 24-hr blood pressure levels in men and women with stage 3-4 kidney disease and hypertension.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •• Non-diabetic and >18 years of age
  • •Diagnosed kidney disease with associated hypertension:
  • •Non-nephrotic range proteinuria at diagnosis
  • •No active glomerular disease or concomitant systemic inflammatory disease (e.g. lupus)
  • •Systolic blood pressure >130 and/or diastolic blood pressure >80 mm Hg (on medication)
  • •An estimated glomerular filtration rate of between 60 ml/min and 15 ml/min.
  • •Individuals must be able to provide informed consent
  • •Perform walking exercise training on a treadmill
  • •Be able to participate in a 12-week supervised exercise program.

排除标准

  • •Currently participating in a formal exercise program
  • •Diabetes, active glomerular disease, or systemic inflammatory disease
  • •Requiring dialysis
  • •Have an Hematocrit <27%
  • •Uncontrolled hypertension (>200/110mmHg)
  • •Peripheral vascular disease.
  • •An inability to understand English or give consent. Other exclusion criteria are: any contraindications to exercise testing or training as indicated by the American College of Sports Medicine guidelines such as: Unstable coronary heart disease and symptomatic heart failure, exercise capacity limited by health problems such as angina, severe arthritis, or extreme dyspnea on exertion, progressive neuromuscular disease, pulmonary disease, or having undergone a coronary revascularization within the past 6 months prior to enrollment.

研究组 & 干预措施

Exercise

Experimental

12 weeks of blended supervised-home based exercise 3-4 times per week for 30-45 minutes

干预措施: Exercise (Behavioral)

control

No Intervention

Control group asked to continue usual activities

结局指标

主要结局

blood pressure

时间窗: at week 0 and at week 12

resting and 24-hour ambulatory blood pressure

次要结局

  • effective vascular compliance(at week 0 and at week 12)
  • endothelial function(at week 0 and at week 12)
  • biomarkers associated with blood pressure(at week 0 and at week 12)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验